{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for hydrocortisone root_names_stdName in Standardized Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
NDA020165
(2000)
Source URL:
First approved in 2000
Source:
NDA020165
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2014)
Source URL:
First approved in 1989
Source:
NDA019684
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020907
(1998)
Source URL:
First approved in 1974
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA090931
(1997)
Source URL:
First approved in 1974
Source:
NDA050813
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2021)
Source URL:
First approved in 1968
Source:
ANDA076709
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA077062
(1968)
Source URL:
First approved in 1968
Source:
ANDA077062
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA077154
(1968)
Source URL:
First approved in 1968
Source:
ANDA077154
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA211796
(1955)
Source URL:
First approved in 1955
Source:
ANDA211796
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 338
(2017)
Source URL:
First approved in 1955
Source:
NDA202100
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1950
Source:
NDA007073
Source URL:
Class:
POLYMER
Cellacefate is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations. Cellacefate's use in enteric coatings allows tablets to remain intact in the unfavorable gastric acid secretion of the stomach, but dissolve in the more basic areas of the duodenum, thus protecting the stomach from ulceration or allowing greater absorption form the duodenum. Cellacefate is a reaction product of phthalic anhydride and a partial acetate ester of cellulose.